 |
 |
Browse all recently published reports
May 15, 2008
Daiichi Sankyo/Eli Lilly’s Effient and Astrazeneca’s Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction... more>>
May 13, 2008
Simvastatin Leads Pfizer's Lipitor in Second-Line Patient Share for the Treatment of Dyslipidemia... more>>
May 12, 2008
Launches of at Least 15 New Biologic Therapies by 2017 Will Expand Treatment Options for Immune and Inflammatory Diseases... more>>
View all press releases
|
|
|
 |
|
|
Atypical Antipsychotics Report
Listen to an interview with analyst Sandra Chow in which she discusses the atypical antipsychotics drug market.
Ms. Chow is the author of the Brands & Strategies: Atypical Antipsychotics report. In this interview, Ms. Chow discusses the shifts in market leadership that will continue to characterize the atypical antipsychotics drug market as leading therapies face increasing generic competition.
Listen to Interview
|
|
 |
 |
|
Changes in Physician Sentiment in the Wake of Avandia
Based on our recent Physician and Payer Forum report, Avandia One Year Later: A Physician and Payer Perspective, Decision Resources is offering this exclusive, in-depth webinar on May 22, 2008.
Click here to learn more.
|
|
